Greatland Gold MD Shaun Day will be taking live Q&A on 5th March (4-5PM), please register here and submit questions here. An in-person Town Hall will follow at 6PM, please register here.

Less Ads, More Data, More Tools Register for FREE

Fusion Antibodies shares up on deal with US National Cancer Institute

Tue, 28th Nov 2023 12:09

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Fusion shares surged 43% to 4.94 pence each on Tuesday afternoon in London.

The Belfast-based contract research organisation, providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market, said it will provide the NCI full access to its OptiMAL technology to be used against selected, primarily cancer targets, for a two-year period.

The firm said the deal is aimed at developing potential therapeutic antibodies to treat the selected targets.

As part of the agreement, Fusion said the parties will work together on the validation of its OptiMAL technology, with results to be jointly published. Antibodies identified will be retained by the NCI.

Chief Executive Adrian Kinkaid said: "At the time of our fundraise in May, we said that we would be seeking the support of third parties to continue to progress the delivery of OptiMAL. We are delighted to have been able to secure a partner with the expertise of NCI to provide validation to the technology without Fusion being required to commit significant resource to the project."

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday,...

14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to th...

6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with a...

6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax cred...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.